/Investor DB

Illumina Ventures — 2017 Investments

3 investments dated 2017 · listed companies and verified rows first · show all

Dna Scriptdnascript.comin𝕏Series A · Sep 2017 · $13M

DNA Script develops enzymatic DNA synthesis technology, producing nucleic acids for research and biotech applications.

BiotechDeep TechHardwareParis, FR

Thomas Ybert(Founder)inXavier Godronin

Co-investorsCatalio Capital Management, LPCoatue ManagementKurma PartnersM VenturesSofinnova PartnersCasdin Capital

NanoCellect Biomedicalnanocellect.cominSeries B · Nov 2017 · $10M

Developer of microfluidic cell sorting technologies for the biotech industry.

BiotechHardwareMedical DevicesSan Diego, US

Jose Morachis(Executive Officer, Director)inNate Heintzman(Executive Officer, Director)inWilliam Alaynick(Executive Officer, Director)Chris Neary(CEO)in

BoardKenneth Hood(Director)

Co-investorsVertical Venture PartnersWarburg PincusAnzu PartnersFusionX VenturesHemisphere Ventures LLCPaladin Capital Group

Serimmuneserimmune.comSeries A · Jun 2017 · $8M

BiotechGoleta, US

Patrick Daugherty(Executive Officer, Director)Kristin Loomis(Director)Bill Welch(Director)inNick Naclerio(Director)inJohn Shon(Executive Officer)

Co-investorsIllumina Innovation

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.